SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3af5'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1D4F_B_ADNB602_2 (S-ADENOSYLHOMOCYSTEI NE HYDROLASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 5	THR A 284 THR A 281 THR A 365 HIS A 261	None None None ZN A 665 (-3.3A)	1.32A	1d4fB-3af5A: 2.8	1d4fB-3af5A: 22.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FSL_A_NIOA145_1 (LEGHEMOGLOBIN A)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 8	PHE A 547 ILE A 545 PHE A 534 VAL A 585	None	0.86A	1fslA-3af5A: undetectable	1fslA-3af5A: 14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FWE_C_HAEC989_1 (UREASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 6	HIS A 261 HIS A 344 HIS A 594 HIS A 618 ASP A 260	ZN A 665 (-3.3A) ZN A 662 (-3.4A) SO4 A 657 (-3.4A) ZN A 665 ( 3.3A) ZN A 665 ( 2.9A)	1.32A	1fweC-3af5A: 2.8	1fweC-3af5A: 22.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KGL_A_RTLA175_1 (CELLULAR RETINOL-BINDING PROTEIN TYPE I)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 7	LEU A 625 ILE A 637 THR A 639 MET A 601	None	1.03A	1kglA-3af5A: undetectable	1kglA-3af5A: 12.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ONI_D_BEZD507_0 (14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 7	PHE A 104 ALA A 85 ILE A 113 ILE A 132	None	0.92A	1oniD-3af5A: undetectable 1oniF-3af5A: undetectable	1oniD-3af5A: 12.15 1oniF-3af5A: 12.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOU_B_CQAB401_0 (HISTAMINE N-METHYLTRANSFERASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 7	GLY A 347 ASP A 286 TYR A 472 THR A 322	None None None ACY A 660 (-4.0A)	1.16A	2aouB-3af5A: undetectable	2aouB-3af5A: 17.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AZX_A_TRPA602_0 (TRYPTOPHANYL-TRNA SYNTHETASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 8	LEU A 443 ILE A 452 PHE A 497 ILE A 519	None	0.85A	2azxA-3af5A: undetectable	2azxA-3af5A: 21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BYO_A_LNLA1216_1 (LIPOPROTEIN LPPX)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 5	LEU A 412 ILE A 546 LEU A 427 SER A 544	None	0.86A	2byoA-3af5A: undetectable	2byoA-3af5A: 15.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HDN_F_TACF3888_1 (ELONGATION FACTOR EF-TU)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 7	SER A 203 ASP A 217 VAL A 200 LEU A 600	None	0.97A	2hdnE-3af5A: undetectable 2hdnF-3af5A: 2.2 2hdnH-3af5A: undetectable	2hdnE-3af5A: 4.77 2hdnF-3af5A: 18.50 2hdnH-3af5A: 18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HDN_H_TACH4888_1 (ELONGATION FACTOR EF-TU)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 7	VAL A 200 LEU A 600 SER A 203 ASP A 217	None	1.02A	2hdnF-3af5A: 2.2 2hdnG-3af5A: undetectable 2hdnH-3af5A: undetectable	2hdnF-3af5A: 18.50 2hdnG-3af5A: 4.77 2hdnH-3af5A: 18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HDN_J_TACJ5888_1 (ELONGATION FACTOR EF-TU)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 6	THR A 255 SER A 203 ASP A 217 VAL A 200	None	1.12A	2hdnI-3af5A: undetectable 2hdnJ-3af5A: undetectable 2hdnL-3af5A: undetectable	2hdnI-3af5A: 4.77 2hdnJ-3af5A: 18.50 2hdnL-3af5A: 18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HDN_L_TACL6888_1 (ELONGATION FACTOR EF-TU)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 6	VAL A 200 THR A 255 SER A 203 ASP A 217	None	1.12A	2hdnJ-3af5A: undetectable 2hdnK-3af5A: undetectable 2hdnL-3af5A: undetectable	2hdnJ-3af5A: 18.50 2hdnK-3af5A: 4.77 2hdnL-3af5A: 18.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OTH_A_NIMA300_1 (PHOSPHOLIPASE A2 VRV-PL-VIIIA)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 5	ALA A 465 ILE A 468 SER A 150 LYS A 293	None	1.13A	2othA-3af5A: undetectable	2othA-3af5A: 12.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q0J_B_BEZB500_0 (QUINOLONE SIGNAL RESPONSE PROTEIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 11	ASP A 260 HIS A 261 HIS A 344 ASP A 367 HIS A 618	ZN A 665 ( 2.9A) ZN A 665 (-3.3A) ZN A 662 (-3.4A) ZN A 665 (-2.5A) ZN A 665 ( 3.3A)	0.58A	2q0jB-3af5A: 11.8	2q0jB-3af5A: 19.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QK8_A_MTXA200_1 (DIHYDROFOLATE REDUCTASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 12	ALA A 465 LEU A 346 ILE A 484 LEU A 480 PHE A 492	None	1.22A	2qk8A-3af5A: 2.7	2qk8A-3af5A: 11.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X45_A_HSMA1161_1 (ALLERGEN ARG R 1)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 5	VAL A 390 VAL A 216 ASP A 217 SER A 203	None	1.19A	2x45A-3af5A: undetectable	2x45A-3af5A: 10.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2X45_C_HSMC1161_1 (ALLERGEN ARG R 1)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 5	VAL A 390 VAL A 216 ASP A 217 SER A 203	None	1.29A	2x45C-3af5A: undetectable	2x45C-3af5A: 10.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XAD_E_GCSE710_1 (N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE TEICOPLANIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 8	HIS A 344 ARG A 435 HIS A 256 ASP A 367	ZN A 662 (-3.4A) SO4 A 654 (-3.7A) ZN A 662 (-3.4A) ZN A 665 (-2.5A)	1.04A	2xadA-3af5A: undetectable	2xadA-3af5A: 16.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XAD_F_GCSF710_1 (N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE TEICOPLANIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 8	HIS A 344 ARG A 435 HIS A 256 ASP A 367	ZN A 662 (-3.4A) SO4 A 654 (-3.7A) ZN A 662 (-3.4A) ZN A 665 (-2.5A)	0.99A	2xadB-3af5A: undetectable	2xadB-3af5A: 16.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XAD_G_GCSG710_1 (N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE TEICOPLANIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 8	HIS A 344 ARG A 435 HIS A 256 ASP A 367	ZN A 662 (-3.4A) SO4 A 654 (-3.7A) ZN A 662 (-3.4A) ZN A 665 (-2.5A)	1.02A	2xadC-3af5A: undetectable	2xadC-3af5A: 16.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XAD_H_GCSH710_1 (N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE TEICOPLANIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 8	HIS A 344 ARG A 435 HIS A 256 ASP A 367	ZN A 662 (-3.4A) SO4 A 654 (-3.7A) ZN A 662 (-3.4A) ZN A 665 (-2.5A)	1.03A	2xadD-3af5A: undetectable	2xadD-3af5A: 16.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YQZ_A_SAMA301_1 (HYPOTHETICAL PROTEIN TTHA0223)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 5	TYR A 550 ARG A 558 ASP A 260 ASP A 217	None None ZN A 665 ( 2.9A) None	1.45A	2yqzA-3af5A: 2.3	2yqzA-3af5A: 18.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YQZ_B_SAMB401_1 (HYPOTHETICAL PROTEIN TTHA0223)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 5	TYR A 550 ARG A 558 ASP A 260 ASP A 217	None None ZN A 665 ( 2.9A) None	1.44A	2yqzB-3af5A: 2.3	2yqzB-3af5A: 18.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YVL_B_SAMB602_1 (HYPOTHETICAL PROTEIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	3 / 3	GLU A 464 ASP A 286 TYR A 472	None	0.88A	2yvlB-3af5A: 2.5	2yvlB-3af5A: 18.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ELZ_B_CHDB200_0 (ILEAL BILE ACID-BINDING PROTEIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 5	PRO A 611 VAL A 607 THR A 255 GLY A 366	None	1.00A	3elzB-3af5A: undetectable	3elzB-3af5A: 12.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JW5_B_TOPB208_1 (DIHYDROFOLATE REDUCTASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 10	ALA A 465 LEU A 346 ILE A 484 LEU A 480 PHE A 492	None	1.14A	3jw5B-3af5A: undetectable	3jw5B-3af5A: 11.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KP6_B_SALB3004_1 (TRANSCRIPTIONAL REGULATOR TCAR)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 5	ILE A 102 PHE A 104 ASP A 105 GLU A 110	None	0.83A	3kp6A-3af5A: undetectable 3kp6B-3af5A: undetectable	3kp6A-3af5A: 13.80 3kp6B-3af5A: 13.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KPB_A_SAMA1000_0 (UNCHARACTERIZED PROTEIN MJ0100)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 12	ILE A 189 ASP A 334 THR A 209 ILE A 191 ILE A 362	None	1.18A	3kpbA-3af5A: undetectable	3kpbA-3af5A: 10.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KPB_C_SAMC1000_0 (UNCHARACTERIZED PROTEIN MJ0100)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 12	ILE A 189 ASP A 334 THR A 209 ILE A 191 ILE A 362	None	1.18A	3kpbC-3af5A: undetectable	3kpbC-3af5A: 10.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KPB_D_SAMD1000_0 (UNCHARACTERIZED PROTEIN MJ0100)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 10	ILE A 189 ASP A 334 THR A 209 ILE A 191 ILE A 362	None	1.18A	3kpbD-3af5A: undetectable	3kpbD-3af5A: 10.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MSS_A_STIA1_2 (TYROSINE-PROTEIN KINASE ABL1)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 6	VAL A 531 ILE A 298 MET A 569 ARG A 435	None None None SO4 A 654 (-3.7A)	1.06A	3mssA-3af5A: undetectable	3mssA-3af5A: 18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MSS_C_STIC1_2 (TYROSINE-PROTEIN KINASE ABL1)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 6	VAL A 531 ILE A 298 MET A 569 ARG A 435	None None None SO4 A 654 (-3.7A)	1.07A	3mssC-3af5A: undetectable	3mssC-3af5A: 18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PYY_A_STIA3_2 (V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 ISOFORM B VARIANT)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 6	VAL A 328 VAL A 351 ILE A 331 ARG A 385	None None None SO4 A 656 (-3.9A)	1.09A	3pyyA-3af5A: undetectable	3pyyA-3af5A: 18.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SI7_D_ACTD4_0 (CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 5	LEU A 215 LEU A 194 GLY A 195 GLY A 193	None	0.68A	3si7C-3af5A: undetectable 3si7D-3af5A: undetectable	3si7C-3af5A: 18.24 3si7D-3af5A: 18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SUF_B_SUEB1201_3 (NS3 PROTEASE, NS4A PROTEIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 5	SER A 71 ARG A 73 PRO A 74 VAL A 46	None	1.01A	3sufC-3af5A: undetectable	3sufC-3af5A: 14.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TMZ_A_06XA504_1 (CYTOCHROME P450 2B4)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 9	LEU A 194 LEU A 215 ILE A 362 ILE A 189 GLN A 208	None	1.49A	3tmzA-3af5A: undetectable	3tmzA-3af5A: 23.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W1W_B_CHDB504_0 (FERROCHELATASE, MITOCHONDRIAL)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 12	LEU A 339 LEU A 323 ILE A 364 PRO A 277 VAL A 214	None	1.38A	3w1wB-3af5A: 4.1	3w1wB-3af5A: 20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W37_A_ACRA1001_1 (ALPHA-GLUCOSIDASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 12	ALA A 342 ASN A 341 ASP A 260 ASP A 217 HIS A 618	None ACY A 658 (-3.4A) ZN A 665 ( 2.9A) None ZN A 665 ( 3.3A)	1.28A	3w37A-3af5A: undetectable	3w37A-3af5A: 22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WEL_A_ACRA1001_1 (ALPHA-GLUCOSIDASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 12	ALA A 342 ASN A 341 ASP A 260 ASP A 217 HIS A 618	None ACY A 658 (-3.4A) ZN A 665 ( 2.9A) None ZN A 665 ( 3.3A)	1.29A	3welA-3af5A: undetectable	3welA-3af5A: 22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WEM_A_ACRA1001_1 (ALPHA-GLUCOSIDASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 12	ALA A 342 ASN A 341 ASP A 260 ASP A 217 HIS A 618	None ACY A 658 (-3.4A) ZN A 665 ( 2.9A) None ZN A 665 ( 3.3A)	1.30A	3wemA-3af5A: 2.1	3wemA-3af5A: 22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WEN_A_ACRA1001_1 (ALPHA-GLUCOSIDASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 12	ALA A 342 ASN A 341 ASP A 260 ASP A 217 HIS A 618	None ACY A 658 (-3.4A) ZN A 665 ( 2.9A) None ZN A 665 ( 3.3A)	1.30A	3wenA-3af5A: 2.1	3wenA-3af5A: 22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WEO_A_ACRA1001_1 (ALPHA-GLUCOSIDASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 12	ALA A 342 ASN A 341 ASP A 260 ASP A 217 HIS A 618	None ACY A 658 (-3.4A) ZN A 665 ( 2.9A) None ZN A 665 ( 3.3A)	1.31A	3weoA-3af5A: undetectable	3weoA-3af5A: 22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ACA_B_DXCB1473_0 (TRANSLATION ELONGATION FACTOR SELB)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 9	ASP A 589 ILE A 588 GLY A 590 PHE A 591 VAL A 415	None	1.32A	4acaB-3af5A: 2.7 4acaC-3af5A: 2.6	4acaB-3af5A: 22.65 4acaC-3af5A: 22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ACB_B_DXCB1473_0 (TRANSLATION ELONGATION FACTOR SELB)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 8	ASP A 589 ILE A 588 GLY A 590 PHE A 591 VAL A 415	None	1.31A	4acbB-3af5A: 2.7 4acbC-3af5A: 2.2	4acbB-3af5A: 22.65 4acbC-3af5A: 22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BLV_A_SAMA1281_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE J)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 12	LEU A 476 TYR A 472 GLY A 347 LEU A 375 GLY A 434	None None None None SO4 A 654 (-3.4A)	1.08A	4blvA-3af5A: 2.4	4blvA-3af5A: 17.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C1D_B_X8ZB350_1 (BETA-LACTAMASE CLASS B VIM-2)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 10	HIS A 256 HIS A 258 ASP A 260 HIS A 344 HIS A 618	ZN A 662 (-3.4A) ZN A 662 ( 3.3A) ZN A 665 ( 2.9A) ZN A 662 (-3.4A) ZN A 665 ( 3.3A)	0.87A	4c1dB-3af5A: 9.1	4c1dB-3af5A: 17.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C1D_B_X8ZB350_1 (BETA-LACTAMASE CLASS B VIM-2)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 10	TYR A 550 HIS A 256 HIS A 258 ASP A 260 HIS A 344	None ZN A 662 (-3.4A) ZN A 662 ( 3.3A) ZN A 665 ( 2.9A) ZN A 662 (-3.4A)	1.41A	4c1dB-3af5A: 9.1	4c1dB-3af5A: 17.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C1F_A_X8ZA300_1 (BETA-LACTAMASE IMP-1)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 11	HIS A 256 HIS A 258 ASP A 260 HIS A 344 HIS A 618	ZN A 662 (-3.4A) ZN A 662 ( 3.3A) ZN A 665 ( 2.9A) ZN A 662 (-3.4A) ZN A 665 ( 3.3A)	0.90A	4c1fA-3af5A: 9.7 4c1fB-3af5A: 2.7	4c1fA-3af5A: 16.46 4c1fB-3af5A: 16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C1H_A_X8ZA305_1 (BETA-LACTAMASE 2)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 9	HIS A 256 HIS A 258 ASP A 260 HIS A 344 HIS A 618	ZN A 662 (-3.4A) ZN A 662 ( 3.3A) ZN A 665 ( 2.9A) ZN A 662 (-3.4A) ZN A 665 ( 3.3A)	0.90A	4c1hA-3af5A: 8.6	4c1hA-3af5A: 17.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EXS_B_X8ZB301_1 (BETA-LACTAMASE NDM-1)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 8	HIS A 258 ASP A 260 HIS A 344 HIS A 618	ZN A 662 ( 3.3A) ZN A 665 ( 2.9A) ZN A 662 (-3.4A) ZN A 665 ( 3.3A)	0.81A	4exsB-3af5A: 9.7	4exsB-3af5A: 17.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KOW_A_CFXA204_1 (UNCHARACTERIZED PROTEIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 12	PHE A 235 PRO A 233 GLY A 193 ASN A 644 LEU A 215	None None None SO4 A 652 (-4.0A) None	1.10A	4kowA-3af5A: undetectable	4kowA-3af5A: 14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UCK_B_SAMB2409_1 (RNA-DIRECTED RNA POLYMERASE L)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 6	GLY A 109 GLU A 110 ASP A 75 ASP A 105	None	0.99A	4uckB-3af5A: undetectable	4uckB-3af5A: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WQ5_B_ACTB404_0 (TRNA N6-ADENOSINE THREONYLCARBAMOYLTRA NSFERASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	3 / 3	TYR A 229 ARG A 202 LYS A 230	SO4 A 652 (-3.8A) SO4 A 652 (-3.8A) SO4 A 652 (-3.1A)	1.38A	4wq5B-3af5A: undetectable	4wq5B-3af5A: 19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5A5Z_A_WJZA304_0 (BETA-LACTAMASE NDM-1)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 8	HIS A 258 ASP A 260 HIS A 344 HIS A 618	ZN A 662 ( 3.3A) ZN A 665 ( 2.9A) ZN A 662 (-3.4A) ZN A 665 ( 3.3A)	0.76A	5a5zA-3af5A: 8.5	5a5zA-3af5A: 16.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5A5Z_A_WJZA304_0 (BETA-LACTAMASE NDM-1)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 8	VAL A 200 HIS A 258 HIS A 344 HIS A 618	None ZN A 662 ( 3.3A) ZN A 662 (-3.4A) ZN A 665 ( 3.3A)	0.81A	5a5zA-3af5A: 8.5	5a5zA-3af5A: 16.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5AYA_A_X8ZA307_1 (METALLO-BETA-LACTAMA SE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	6 / 11	HIS A 256 HIS A 258 ASP A 260 HIS A 261 HIS A 344 HIS A 618	ZN A 662 (-3.4A) ZN A 662 ( 3.3A) ZN A 665 ( 2.9A) ZN A 665 (-3.3A) ZN A 662 (-3.4A) ZN A 665 ( 3.3A)	0.40A	5ayaA-3af5A: 11.4	5ayaA-3af5A: 17.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LJE_A_RTLA201_1 (RETINOL-BINDING PROTEIN 1)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 6	LEU A 625 ILE A 637 THR A 639 MET A 601	None	1.10A	5ljeA-3af5A: undetectable	5ljeA-3af5A: 12.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MZR_A_PFLA412_1 (PROTON-GATED ION CHANNEL)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 10	PRO A 455 TYR A 457 ILE A 518 ILE A 517 ILE A 420	None	1.47A	5mzrA-3af5A: undetectable	5mzrA-3af5A: 8.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MZR_C_PFLC409_1 (PROTON-GATED ION CHANNEL)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 10	PRO A 455 TYR A 457 ILE A 518 ILE A 517 ILE A 420	None	1.45A	5mzrC-3af5A: undetectable	5mzrC-3af5A: 8.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MZR_D_PFLD410_1 (PROTON-GATED ION CHANNEL)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 9	PRO A 455 TYR A 457 ILE A 518 ILE A 517 ILE A 420	None	1.47A	5mzrD-3af5A: undetectable	5mzrD-3af5A: 8.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZW_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	7 / 10	HIS A 256 HIS A 258 HIS A 261 HIS A 344 ASP A 367 TYR A 395 HIS A 594	ZN A 662 (-3.4A) ZN A 662 ( 3.3A) ZN A 665 (-3.3A) ZN A 662 (-3.4A) ZN A 665 (-2.5A) None SO4 A 657 (-3.4A)	0.43A	5nzwA-3af5A: 23.0	5nzwA-3af5A: 20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZW_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 10	HIS A 256 HIS A 344 HIS A 261 THR A 616 HIS A 618	ZN A 662 (-3.4A) ZN A 662 (-3.4A) ZN A 665 (-3.3A) None ZN A 665 ( 3.3A)	1.12A	5nzwA-3af5A: 23.0	5nzwA-3af5A: 20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZW_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 10	HIS A 261 HIS A 618 HIS A 256 ASP A 367 HIS A 344	ZN A 665 (-3.3A) ZN A 665 ( 3.3A) ZN A 662 (-3.4A) ZN A 665 (-2.5A) ZN A 662 (-3.4A)	1.06A	5nzwA-3af5A: 23.0	5nzwA-3af5A: 20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NZW_A_9F2A1102_1 (DNA CROSS-LINK REPAIR 1A PROTEIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 10	HIS A 344 HIS A 256 HIS A 594 ASP A 367 HIS A 618	ZN A 662 (-3.4A) ZN A 662 (-3.4A) SO4 A 657 (-3.4A) ZN A 665 (-2.5A) ZN A 665 ( 3.3A)	1.05A	5nzwA-3af5A: 23.0	5nzwA-3af5A: 20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCV_A_1N1A404_2 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 5	VAL A 207 HIS A 354 LEU A 650 ASP A 334	None SO4 A 656 (-3.7A) None None	1.37A	5vcvA-3af5A: undetectable	5vcvA-3af5A: 18.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XIO_A_HFGA801_1 (PROLINE-TRNA SYNTHETASE CLASS II AARS (YBAK RNA BINDING DOMAIN PLUS TRNA SYNTHETASE))	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	3 / 3	THR A 394 GLU A 392 HIS A 344	None None ZN A 662 (-3.4A)	0.80A	5xioA-3af5A: undetectable	5xioA-3af5A: 21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XIQ_B_HFGB1002_1 (PROLYL-TRNA SYNTHETASE (PRORS))	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	3 / 3	THR A 394 GLU A 392 HIS A 344	None None ZN A 662 (-3.4A)	0.81A	5xiqB-3af5A: undetectable	5xiqB-3af5A: 22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XIQ_D_HFGD1002_1 (PROLYL-TRNA SYNTHETASE (PRORS))	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	3 / 3	THR A 394 GLU A 392 HIS A 344	None None ZN A 662 (-3.4A)	0.82A	5xiqD-3af5A: undetectable	5xiqD-3af5A: 22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YOD_B_BEZB201_0 (NS3 PROTEASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 5	ALA A 342 SER A 348 GLY A 347 TYR A 325	None	1.08A	5yodB-3af5A: undetectable	5yodB-3af5A: 16.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YOD_D_BEZD201_0 (NS3 PROTEASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 5	ALA A 342 SER A 348 GLY A 347 TYR A 325	None	1.15A	5yodD-3af5A: undetectable	5yodD-3af5A: 16.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZJ8_A_9DCA303_0 (METALLO-BETA-LACTAMA SE TYPE 2)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 8	HIS A 258 ASP A 260 HIS A 256 HIS A 618	ZN A 662 ( 3.3A) ZN A 665 ( 2.9A) ZN A 662 (-3.4A) ZN A 665 ( 3.3A)	1.04A	5zj8A-3af5A: 9.6	5zj8A-3af5A: 16.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZJ8_A_9DCA303_0 (METALLO-BETA-LACTAMA SE TYPE 2)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 8	HIS A 258 ASP A 260 HIS A 344 HIS A 618	ZN A 662 ( 3.3A) ZN A 665 ( 2.9A) ZN A 662 (-3.4A) ZN A 665 ( 3.3A)	0.85A	5zj8A-3af5A: 9.6	5zj8A-3af5A: 16.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AJI_A_AY6A1001_0 (DRUG EXPORTERS OF THE RND SUPERFAMILY-LIKE PROTEIN,ENDOLYSIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 12	VAL A 426 ILE A 456 ILE A 416 LEU A 458 ALA A 520	None	1.17A	6ajiA-3af5A: undetectable	6ajiA-3af5A: 21.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EMU_A_SAMA501_0 (TRNA (GUANINE(9)-/ADENINE (9)-N1)-METHYLTRANSF ERASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 12	LEU A 458 ILE A 462 GLY A 460 ILE A 456 ILE A 519	None	0.86A	6emuA-3af5A: undetectable	6emuA-3af5A: 15.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EMU_C_SAMC301_0 (TRNA (GUANINE(9)-/ADENINE (9)-N1)-METHYLTRANSF ERASE)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	5 / 12	LEU A 458 ILE A 462 GLY A 460 ILE A 456 ILE A 519	None	0.89A	6emuC-3af5A: undetectable	6emuC-3af5A: 15.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_F_TA1F502_2 (TUBULIN BETA CHAIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 5	LEU A 205 LEU A 353 THR A 365 PRO A 609	None	1.00A	6ew0F-3af5A: undetectable	6ew0F-3af5A: 8.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_G_TA1G501_2 (TUBULIN BETA CHAIN)	3af5	PUTATIVE UNCHARACTERIZED PROTEIN PH1404 (Pyrococcus horikoshii)	4 / 6	LEU A 205 LEU A 353 THR A 365 PRO A 609	None	1.00A	6ew0G-3af5A: undetectable	6ew0G-3af5A: 8.84

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1D4F_B_ADNB602_2","S-ADENOSYLHOMOCYSTEINE HYDROLASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"THR A 284;THR A 281;THR A 365;HIS A 261","None;None;None; ZN A 665 (-3.3A)","1.32A","1d4fB-3af5A:2.8","1d4fB-3af5A:22.46"],["1FSL_A_NIOA145_1","LEGHEMOGLOBIN A","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"PHE A 547;ILE A 545;PHE A 534;VAL A 585","None","0.86A","1fslA-3af5A:undetectable","1fslA-3af5A:14.81"],["1FWE_C_HAEC989_1","UREASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"HIS A 261;HIS A 344;HIS A 594;HIS A 618;ASP A 260"," ZN A 665 (-3.3A); ZN A 662 (-3.4A);SO4 A 657 (-3.4A); ZN A 665 ( 3.3A); ZN A 665 ( 2.9A)","1.32A","1fweC-3af5A:2.8","1fweC-3af5A:22.73"],["1KGL_A_RTLA175_1","CELLULAR RETINOL-BINDING PROTEIN TYPE I","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"LEU A 625;ILE A 637;THR A 639;MET A 601","None","1.03A","1kglA-3af5A:undetectable","1kglA-3af5A:12.34"],["1ONI_D_BEZD507_0","14.5 KDA TRANSLATIONAL INHIBITOR PROTEIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"PHE A 104;ALA A  85;ILE A 113;ILE A 132","None","0.92A","1oniD-3af5A:undetectable;1oniF-3af5A:undetectable","1oniD-3af5A:12.15;1oniF-3af5A:12.15"],["2AOU_B_CQAB401_0","HISTAMINE N-METHYLTRANSFERASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"GLY A 347;ASP A 286;TYR A 472;THR A 322","None;None;None;ACY A 660 (-4.0A)","1.16A","2aouB-3af5A:undetectable","2aouB-3af5A:17.90"],["2AZX_A_TRPA602_0","TRYPTOPHANYL-TRNA SYNTHETASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"LEU A 443;ILE A 452;PHE A 497;ILE A 519","None","0.85A","2azxA-3af5A:undetectable","2azxA-3af5A:21.63"],["2BYO_A_LNLA1216_1","LIPOPROTEIN LPPX","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"LEU A 412;ILE A 546;LEU A 427;SER A 544","None","0.86A","2byoA-3af5A:undetectable","2byoA-3af5A:15.28"],["2HDN_F_TACF3888_1","ELONGATION FACTOR EF-TU;ELONGATION FACTOR EF-TU;ELONGATION FACTOR EF-TU","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"SER A 203;ASP A 217;VAL A 200;LEU A 600","None","0.97A","2hdnE-3af5A:undetectable;2hdnF-3af5A:2.2;2hdnH-3af5A:undetectable","2hdnE-3af5A:4.77;2hdnF-3af5A:18.50;2hdnH-3af5A:18.50"],["2HDN_H_TACH4888_1","ELONGATION FACTOR EF-TU;ELONGATION FACTOR EF-TU;ELONGATION FACTOR EF-TU","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"VAL A 200;LEU A 600;SER A 203;ASP A 217","None","1.02A","2hdnF-3af5A:2.2;2hdnG-3af5A:undetectable;2hdnH-3af5A:undetectable","2hdnF-3af5A:18.50;2hdnG-3af5A:4.77;2hdnH-3af5A:18.50"],["2HDN_J_TACJ5888_1","ELONGATION FACTOR EF-TU;ELONGATION FACTOR EF-TU;ELONGATION FACTOR EF-TU","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"THR A 255;SER A 203;ASP A 217;VAL A 200","None","1.12A","2hdnI-3af5A:undetectable;2hdnJ-3af5A:undetectable;2hdnL-3af5A:undetectable","2hdnI-3af5A:4.77;2hdnJ-3af5A:18.50;2hdnL-3af5A:18.50"],["2HDN_L_TACL6888_1","ELONGATION FACTOR EF-TU;ELONGATION FACTOR EF-TU;ELONGATION FACTOR EF-TU","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"VAL A 200;THR A 255;SER A 203;ASP A 217","None","1.12A","2hdnJ-3af5A:undetectable;2hdnK-3af5A:undetectable;2hdnL-3af5A:undetectable","2hdnJ-3af5A:18.50;2hdnK-3af5A:4.77;2hdnL-3af5A:18.50"],["2OTH_A_NIMA300_1","PHOSPHOLIPASE A2 VRV-PL-VIIIA","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"ALA A 465;ILE A 468;SER A 150;LYS A 293","None","1.13A","2othA-3af5A:undetectable","2othA-3af5A:12.45"],["2Q0J_B_BEZB500_0","QUINOLONE SIGNAL RESPONSE PROTEIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"ASP A 260;HIS A 261;HIS A 344;ASP A 367;HIS A 618"," ZN A 665 ( 2.9A); ZN A 665 (-3.3A); ZN A 662 (-3.4A); ZN A 665 (-2.5A); ZN A 665 ( 3.3A)","0.58A","2q0jB-3af5A:11.8","2q0jB-3af5A:19.88"],["2QK8_A_MTXA200_1","DIHYDROFOLATE REDUCTASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"ALA A 465;LEU A 346;ILE A 484;LEU A 480;PHE A 492","None","1.22A","2qk8A-3af5A:2.7","2qk8A-3af5A:11.40"],["2X45_A_HSMA1161_1","ALLERGEN ARG R 1","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"VAL A 390;VAL A 216;ASP A 217;SER A 203","None","1.19A","2x45A-3af5A:undetectable","2x45A-3af5A:10.31"],["2X45_C_HSMC1161_1","ALLERGEN ARG R 1","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"VAL A 390;VAL A 216;ASP A 217;SER A 203","None","1.29A","2x45C-3af5A:undetectable","2x45C-3af5A:10.31"],["2XAD_E_GCSE710_1","N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE;TEICOPLANIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"HIS A 344;ARG A 435;HIS A 256;ASP A 367"," ZN A 662 (-3.4A);SO4 A 654 (-3.7A); ZN A 662 (-3.4A); ZN A 665 (-2.5A)","1.04A","2xadA-3af5A:undetectable","2xadA-3af5A:16.64"],["2XAD_F_GCSF710_1","N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE;TEICOPLANIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"HIS A 344;ARG A 435;HIS A 256;ASP A 367"," ZN A 662 (-3.4A);SO4 A 654 (-3.7A); ZN A 662 (-3.4A); ZN A 665 (-2.5A)","0.99A","2xadB-3af5A:undetectable","2xadB-3af5A:16.64"],["2XAD_G_GCSG710_1","N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE;TEICOPLANIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"HIS A 344;ARG A 435;HIS A 256;ASP A 367"," ZN A 662 (-3.4A);SO4 A 654 (-3.7A); ZN A 662 (-3.4A); ZN A 665 (-2.5A)","1.02A","2xadC-3af5A:undetectable","2xadC-3af5A:16.64"],["2XAD_H_GCSH710_1","N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE;TEICOPLANIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"HIS A 344;ARG A 435;HIS A 256;ASP A 367"," ZN A 662 (-3.4A);SO4 A 654 (-3.7A); ZN A 662 (-3.4A); ZN A 665 (-2.5A)","1.03A","2xadD-3af5A:undetectable","2xadD-3af5A:16.64"],["2YQZ_A_SAMA301_1","HYPOTHETICAL PROTEIN TTHA0223","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"TYR A 550;ARG A 558;ASP A 260;ASP A 217","None;None; ZN A 665 ( 2.9A);None","1.45A","2yqzA-3af5A:2.3","2yqzA-3af5A:18.13"],["2YQZ_B_SAMB401_1","HYPOTHETICAL PROTEIN TTHA0223","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"TYR A 550;ARG A 558;ASP A 260;ASP A 217","None;None; ZN A 665 ( 2.9A);None","1.44A","2yqzB-3af5A:2.3","2yqzB-3af5A:18.13"],["2YVL_B_SAMB602_1","HYPOTHETICAL PROTEIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",3,"GLU A 464;ASP A 286;TYR A 472","None","0.88A","2yvlB-3af5A:2.5","2yvlB-3af5A:18.03"],["3ELZ_B_CHDB200_0","ILEAL BILE ACID-BINDING PROTEIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"PRO A 611;VAL A 607;THR A 255;GLY A 366","None","1.00A","3elzB-3af5A:undetectable","3elzB-3af5A:12.23"],["3JW5_B_TOPB208_1","DIHYDROFOLATE REDUCTASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"ALA A 465;LEU A 346;ILE A 484;LEU A 480;PHE A 492","None","1.14A","3jw5B-3af5A:undetectable","3jw5B-3af5A:11.86"],["3KP6_B_SALB3004_1","TRANSCRIPTIONAL REGULATOR TCAR;TRANSCRIPTIONAL REGULATOR TCAR","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"ILE A 102;PHE A 104;ASP A 105;GLU A 110","None","0.83A","3kp6A-3af5A:undetectable;3kp6B-3af5A:undetectable","3kp6A-3af5A:13.80;3kp6B-3af5A:13.80"],["3KPB_A_SAMA1000_0","UNCHARACTERIZED PROTEIN MJ0100","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"ILE A 189;ASP A 334;THR A 209;ILE A 191;ILE A 362","None","1.18A","3kpbA-3af5A:undetectable","3kpbA-3af5A:10.85"],["3KPB_C_SAMC1000_0","UNCHARACTERIZED PROTEIN MJ0100","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"ILE A 189;ASP A 334;THR A 209;ILE A 191;ILE A 362","None","1.18A","3kpbC-3af5A:undetectable","3kpbC-3af5A:10.85"],["3KPB_D_SAMD1000_0","UNCHARACTERIZED PROTEIN MJ0100","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"ILE A 189;ASP A 334;THR A 209;ILE A 191;ILE A 362","None","1.18A","3kpbD-3af5A:undetectable","3kpbD-3af5A:10.85"],["3MSS_A_STIA1_2","TYROSINE-PROTEIN KINASE ABL1","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"VAL A 531;ILE A 298;MET A 569;ARG A 435","None;None;None;SO4 A 654 (-3.7A)","1.06A","3mssA-3af5A:undetectable","3mssA-3af5A:18.82"],["3MSS_C_STIC1_2","TYROSINE-PROTEIN KINASE ABL1","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"VAL A 531;ILE A 298;MET A 569;ARG A 435","None;None;None;SO4 A 654 (-3.7A)","1.07A","3mssC-3af5A:undetectable","3mssC-3af5A:18.82"],["3PYY_A_STIA3_2","V-ABL ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1 ISOFORM B VARIANT","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"VAL A 328;VAL A 351;ILE A 331;ARG A 385","None;None;None;SO4 A 656 (-3.9A)","1.09A","3pyyA-3af5A:undetectable","3pyyA-3af5A:18.02"],["3SI7_D_ACTD4_0","CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"LEU A 215;LEU A 194;GLY A 195;GLY A 193","None","0.68A","3si7C-3af5A:undetectable;3si7D-3af5A:undetectable","3si7C-3af5A:18.24;3si7D-3af5A:18.24"],["3SUF_B_SUEB1201_3","NS3 PROTEASE, NS4A PROTEIN;NS3 PROTEASE, NS4A PROTEIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"SER A  71;ARG A  73;PRO A  74;VAL A  46","None","1.01A","3sufC-3af5A:undetectable","3sufC-3af5A:14.66"],["3TMZ_A_06XA504_1","CYTOCHROME P450 2B4","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"LEU A 194;LEU A 215;ILE A 362;ILE A 189;GLN A 208","None","1.49A","3tmzA-3af5A:undetectable","3tmzA-3af5A:23.48"],["3W1W_B_CHDB504_0","FERROCHELATASE, MITOCHONDRIAL","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"LEU A 339;LEU A 323;ILE A 364;PRO A 277;VAL A 214","None","1.38A","3w1wB-3af5A:4.1","3w1wB-3af5A:20.65"],["3W37_A_ACRA1001_1","ALPHA-GLUCOSIDASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"ALA A 342;ASN A 341;ASP A 260;ASP A 217;HIS A 618","None;ACY A 658 (-3.4A); ZN A 665 ( 2.9A);None; ZN A 665 ( 3.3A)","1.28A","3w37A-3af5A:undetectable","3w37A-3af5A:22.03"],["3WEL_A_ACRA1001_1","ALPHA-GLUCOSIDASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"ALA A 342;ASN A 341;ASP A 260;ASP A 217;HIS A 618","None;ACY A 658 (-3.4A); ZN A 665 ( 2.9A);None; ZN A 665 ( 3.3A)","1.29A","3welA-3af5A:undetectable","3welA-3af5A:22.03"],["3WEM_A_ACRA1001_1","ALPHA-GLUCOSIDASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"ALA A 342;ASN A 341;ASP A 260;ASP A 217;HIS A 618","None;ACY A 658 (-3.4A); ZN A 665 ( 2.9A);None; ZN A 665 ( 3.3A)","1.30A","3wemA-3af5A:2.1","3wemA-3af5A:22.03"],["3WEN_A_ACRA1001_1","ALPHA-GLUCOSIDASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"ALA A 342;ASN A 341;ASP A 260;ASP A 217;HIS A 618","None;ACY A 658 (-3.4A); ZN A 665 ( 2.9A);None; ZN A 665 ( 3.3A)","1.30A","3wenA-3af5A:2.1","3wenA-3af5A:22.03"],["3WEO_A_ACRA1001_1","ALPHA-GLUCOSIDASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"ALA A 342;ASN A 341;ASP A 260;ASP A 217;HIS A 618","None;ACY A 658 (-3.4A); ZN A 665 ( 2.9A);None; ZN A 665 ( 3.3A)","1.31A","3weoA-3af5A:undetectable","3weoA-3af5A:22.03"],["4ACA_B_DXCB1473_0","TRANSLATION ELONGATION FACTOR SELB","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"ASP A 589;ILE A 588;GLY A 590;PHE A 591;VAL A 415","None","1.32A","4acaB-3af5A:2.7;4acaC-3af5A:2.6","4acaB-3af5A:22.65;4acaC-3af5A:22.65"],["4ACB_B_DXCB1473_0","TRANSLATION ELONGATION FACTOR SELB","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"ASP A 589;ILE A 588;GLY A 590;PHE A 591;VAL A 415","None","1.31A","4acbB-3af5A:2.7;4acbC-3af5A:2.2","4acbB-3af5A:22.65;4acbC-3af5A:22.65"],["4BLV_A_SAMA1281_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE J","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"LEU A 476;TYR A 472;GLY A 347;LEU A 375;GLY A 434","None;None;None;None;SO4 A 654 (-3.4A)","1.08A","4blvA-3af5A:2.4","4blvA-3af5A:17.51"],["4C1D_B_X8ZB350_1","BETA-LACTAMASE CLASS B VIM-2","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"HIS A 256;HIS A 258;ASP A 260;HIS A 344;HIS A 618"," ZN A 662 (-3.4A); ZN A 662 ( 3.3A); ZN A 665 ( 2.9A); ZN A 662 (-3.4A); ZN A 665 ( 3.3A)","0.87A","4c1dB-3af5A:9.1","4c1dB-3af5A:17.62"],["4C1D_B_X8ZB350_1","BETA-LACTAMASE CLASS B VIM-2","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"TYR A 550;HIS A 256;HIS A 258;ASP A 260;HIS A 344","None; ZN A 662 (-3.4A); ZN A 662 ( 3.3A); ZN A 665 ( 2.9A); ZN A 662 (-3.4A)","1.41A","4c1dB-3af5A:9.1","4c1dB-3af5A:17.62"],["4C1F_A_X8ZA300_1","BETA-LACTAMASE IMP-1;BETA-LACTAMASE IMP-1","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"HIS A 256;HIS A 258;ASP A 260;HIS A 344;HIS A 618"," ZN A 662 (-3.4A); ZN A 662 ( 3.3A); ZN A 665 ( 2.9A); ZN A 662 (-3.4A); ZN A 665 ( 3.3A)","0.90A","4c1fA-3af5A:9.7;4c1fB-3af5A:2.7","4c1fA-3af5A:16.46;4c1fB-3af5A:16.46"],["4C1H_A_X8ZA305_1","BETA-LACTAMASE 2","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"HIS A 256;HIS A 258;ASP A 260;HIS A 344;HIS A 618"," ZN A 662 (-3.4A); ZN A 662 ( 3.3A); ZN A 665 ( 2.9A); ZN A 662 (-3.4A); ZN A 665 ( 3.3A)","0.90A","4c1hA-3af5A:8.6","4c1hA-3af5A:17.15"],["4EXS_B_X8ZB301_1","BETA-LACTAMASE NDM-1","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"HIS A 258;ASP A 260;HIS A 344;HIS A 618"," ZN A 662 ( 3.3A); ZN A 665 ( 2.9A); ZN A 662 (-3.4A); ZN A 665 ( 3.3A)","0.81A","4exsB-3af5A:9.7","4exsB-3af5A:17.30"],["4KOW_A_CFXA204_1","UNCHARACTERIZED PROTEIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"PHE A 235;PRO A 233;GLY A 193;ASN A 644;LEU A 215","None;None;None;SO4 A 652 (-4.0A);None","1.10A","4kowA-3af5A:undetectable","4kowA-3af5A:14.29"],["4UCK_B_SAMB2409_1","RNA-DIRECTED RNA POLYMERASE L","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"GLY A 109;GLU A 110;ASP A  75;ASP A 105","None","0.99A","4uckB-3af5A:undetectable","4uckB-3af5A:20.91"],["4WQ5_B_ACTB404_0","TRNA N6-ADENOSINE THREONYLCARBAMOYLTRANSFERASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",3,"TYR A 229;ARG A 202;LYS A 230","SO4 A 652 (-3.8A);SO4 A 652 (-3.8A);SO4 A 652 (-3.1A)","1.38A","4wq5B-3af5A:undetectable","4wq5B-3af5A:19.18"],["5A5Z_A_WJZA304_0","BETA-LACTAMASE NDM-1","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"HIS A 258;ASP A 260;HIS A 344;HIS A 618"," ZN A 662 ( 3.3A); ZN A 665 ( 2.9A); ZN A 662 (-3.4A); ZN A 665 ( 3.3A)","0.76A","5a5zA-3af5A:8.5","5a5zA-3af5A:16.74"],["5A5Z_A_WJZA304_0","BETA-LACTAMASE NDM-1","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"VAL A 200;HIS A 258;HIS A 344;HIS A 618","None; ZN A 662 ( 3.3A); ZN A 662 (-3.4A); ZN A 665 ( 3.3A)","0.81A","5a5zA-3af5A:8.5","5a5zA-3af5A:16.74"],["5AYA_A_X8ZA307_1","METALLO-BETA-LACTAMASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",6,"HIS A 256;HIS A 258;ASP A 260;HIS A 261;HIS A 344;HIS A 618"," ZN A 662 (-3.4A); ZN A 662 ( 3.3A); ZN A 665 ( 2.9A); ZN A 665 (-3.3A); ZN A 662 (-3.4A); ZN A 665 ( 3.3A)","0.40A","5ayaA-3af5A:11.4","5ayaA-3af5A:17.34"],["5LJE_A_RTLA201_1","RETINOL-BINDING PROTEIN 1","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"LEU A 625;ILE A 637;THR A 639;MET A 601","None","1.10A","5ljeA-3af5A:undetectable","5ljeA-3af5A:12.14"],["5MZR_A_PFLA412_1","PROTON-GATED ION CHANNEL","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"PRO A 455;TYR A 457;ILE A 518;ILE A 517;ILE A 420","None","1.47A","5mzrA-3af5A:undetectable","5mzrA-3af5A:8.55"],["5MZR_C_PFLC409_1","PROTON-GATED ION CHANNEL","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"PRO A 455;TYR A 457;ILE A 518;ILE A 517;ILE A 420","None","1.45A","5mzrC-3af5A:undetectable","5mzrC-3af5A:8.55"],["5MZR_D_PFLD410_1","PROTON-GATED ION CHANNEL","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"PRO A 455;TYR A 457;ILE A 518;ILE A 517;ILE A 420","None","1.47A","5mzrD-3af5A:undetectable","5mzrD-3af5A:8.55"],["5NZW_A_9F2A1102_1","DNA CROSS-LINK REPAIR 1A PROTEIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",7,"HIS A 256;HIS A 258;HIS A 261;HIS A 344;ASP A 367;TYR A 395;HIS A 594"," ZN A 662 (-3.4A); ZN A 662 ( 3.3A); ZN A 665 (-3.3A); ZN A 662 (-3.4A); ZN A 665 (-2.5A);None;SO4 A 657 (-3.4A)","0.43A","5nzwA-3af5A:23.0","5nzwA-3af5A:20.64"],["5NZW_A_9F2A1102_1","DNA CROSS-LINK REPAIR 1A PROTEIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"HIS A 256;HIS A 344;HIS A 261;THR A 616;HIS A 618"," ZN A 662 (-3.4A); ZN A 662 (-3.4A); ZN A 665 (-3.3A);None; ZN A 665 ( 3.3A)","1.12A","5nzwA-3af5A:23.0","5nzwA-3af5A:20.64"],["5NZW_A_9F2A1102_1","DNA CROSS-LINK REPAIR 1A PROTEIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"HIS A 261;HIS A 618;HIS A 256;ASP A 367;HIS A 344"," ZN A 665 (-3.3A); ZN A 665 ( 3.3A); ZN A 662 (-3.4A); ZN A 665 (-2.5A); ZN A 662 (-3.4A)","1.06A","5nzwA-3af5A:23.0","5nzwA-3af5A:20.64"],["5NZW_A_9F2A1102_1","DNA CROSS-LINK REPAIR 1A PROTEIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"HIS A 344;HIS A 256;HIS A 594;ASP A 367;HIS A 618"," ZN A 662 (-3.4A); ZN A 662 (-3.4A);SO4 A 657 (-3.4A); ZN A 665 (-2.5A); ZN A 665 ( 3.3A)","1.05A","5nzwA-3af5A:23.0","5nzwA-3af5A:20.64"],["5VCV_A_1N1A404_2","MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"VAL A 207;HIS A 354;LEU A 650;ASP A 334","None;SO4 A 656 (-3.7A);None;None","1.37A","5vcvA-3af5A:undetectable","5vcvA-3af5A:18.94"],["5XIO_A_HFGA801_1","PROLINE-TRNA SYNTHETASE CLASS II AARS (YBAK RNA BINDING DOMAIN PLUS TRNA SYNTHETASE)","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",3,"THR A 394;GLU A 392;HIS A 344","None;None; ZN A 662 (-3.4A)","0.80A","5xioA-3af5A:undetectable","5xioA-3af5A:21.12"],["5XIQ_B_HFGB1002_1","PROLYL-TRNA SYNTHETASE (PRORS)","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",3,"THR A 394;GLU A 392;HIS A 344","None;None; ZN A 662 (-3.4A)","0.81A","5xiqB-3af5A:undetectable","5xiqB-3af5A:22.57"],["5XIQ_D_HFGD1002_1","PROLYL-TRNA SYNTHETASE (PRORS)","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",3,"THR A 394;GLU A 392;HIS A 344","None;None; ZN A 662 (-3.4A)","0.82A","5xiqD-3af5A:undetectable","5xiqD-3af5A:22.57"],["5YOD_B_BEZB201_0","NS3 PROTEASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"ALA A 342;SER A 348;GLY A 347;TYR A 325","None","1.08A","5yodB-3af5A:undetectable","5yodB-3af5A:16.38"],["5YOD_D_BEZD201_0","NS3 PROTEASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"ALA A 342;SER A 348;GLY A 347;TYR A 325","None","1.15A","5yodD-3af5A:undetectable","5yodD-3af5A:16.38"],["5ZJ8_A_9DCA303_0","METALLO-BETA-LACTAMASE TYPE 2","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"HIS A 258;ASP A 260;HIS A 256;HIS A 618"," ZN A 662 ( 3.3A); ZN A 665 ( 2.9A); ZN A 662 (-3.4A); ZN A 665 ( 3.3A)","1.04A","5zj8A-3af5A:9.6","5zj8A-3af5A:16.11"],["5ZJ8_A_9DCA303_0","METALLO-BETA-LACTAMASE TYPE 2","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"HIS A 258;ASP A 260;HIS A 344;HIS A 618"," ZN A 662 ( 3.3A); ZN A 665 ( 2.9A); ZN A 662 (-3.4A); ZN A 665 ( 3.3A)","0.85A","5zj8A-3af5A:9.6","5zj8A-3af5A:16.11"],["6AJI_A_AY6A1001_0","DRUG EXPORTERS OF THE RND SUPERFAMILY-LIKE PROTEIN,ENDOLYSIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"VAL A 426;ILE A 456;ILE A 416;LEU A 458;ALA A 520","None","1.17A","6ajiA-3af5A:undetectable","6ajiA-3af5A:21.39"],["6EMU_A_SAMA501_0","TRNA (GUANINE(9)-\/ADENINE(9)-N1)-METHYLTRANSFERASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"LEU A 458;ILE A 462;GLY A 460;ILE A 456;ILE A 519","None","0.86A","6emuA-3af5A:undetectable","6emuA-3af5A:15.68"],["6EMU_C_SAMC301_0","TRNA (GUANINE(9)-\/ADENINE(9)-N1)-METHYLTRANSFERASE","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",5,"LEU A 458;ILE A 462;GLY A 460;ILE A 456;ILE A 519","None","0.89A","6emuC-3af5A:undetectable","6emuC-3af5A:15.68"],["6EW0_F_TA1F502_2","TUBULIN BETA CHAIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"LEU A 205;LEU A 353;THR A 365;PRO A 609","None","1.00A","6ew0F-3af5A:undetectable","6ew0F-3af5A:8.84"],["6EW0_G_TA1G501_2","TUBULIN BETA CHAIN","3af5","PUTATIVE UNCHARACTERIZED PROTEIN PH1404","Pyrococcus horikoshii",4,"LEU A 205;LEU A 353;THR A 365;PRO A 609","None","1.00A","6ew0G-3af5A:undetectable","6ew0G-3af5A:8.84"]]